NYSE:ABBV | Market Exclusive

Home Tags NYSE:ABBV

ABBVIE INC. (NYSE:ABBV) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - May 21, 2018 0

ABBVIE INC. (NYSE:ABBV) Files An 8-K Submission of Matters to a...

ME Staff 8-k - May 9, 2018 0

ABBVIE INC. (NYSE:ABBV) Files An 8-K Temporary Suspension of Trading Under...

ME Staff 8-k - May 2, 2018 0

Analyst Activity – Morgan Stanley Lowers Its Price Target On NYSE:ABBV...

ME Staff - April 30, 2018 0

Analyst Activity – Credit Suisse Group Lowers Its Price Target On...

ME Staff - April 27, 2018 0

AbbVie (NYSE:ABBV) reported earnings of $1.87 per share beating Walls Streets...

ME Staff - April 26, 2018 0

Analyst Activity – Credit Suisse Group Lowers Its Price Target On...

ME Staff - March 23, 2018 0

Analyst Activity – BMO Capital Markets Reiterates Underperform on AbbVie (NYSE:ABBV)...

ME Staff - March 23, 2018 0

Is The AbbVie Dip A Buying Opportunity?

ME Staff - March 23, 2018 0

Here Are Today’s Biotech Movers: Abbvie, Neurocrine and GW Pharmaceuticals

- February 23, 2018 0

1...456...13 Page 5 of 13

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NYSE:ABBV

ABBVIE INC. (NYSE:ABBV) Files An 8-K Entry into a Material Definitive...

ABBVIE INC. (NYSE:ABBV) Files An 8-K Submission of Matters to a...

ABBVIE INC. (NYSE:ABBV) Files An 8-K Temporary Suspension of Trading Under...

Analyst Activity – Morgan Stanley Lowers Its Price Target On NYSE:ABBV...

Analyst Activity – Credit Suisse Group Lowers Its Price Target On...

AbbVie (NYSE:ABBV) reported earnings of $1.87 per share beating Walls Streets...

Analyst Activity – Credit Suisse Group Lowers Its Price Target On...

Analyst Activity – BMO Capital Markets Reiterates Underperform on AbbVie (NYSE:ABBV)...

Is The AbbVie Dip A Buying Opportunity?

Here Are Today’s Biotech Movers: Abbvie, Neurocrine and GW Pharmaceuticals

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY